CIK 0001357874 · Biological Products, (No Diagnostic Substances) (SIC 2836) · Nasdaq · incorporated in DE · fiscal year ends 05/21
| FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|
| Revenue (USD) | 34.3 M | 48.7 M | 25.1 M | |
| Net income (USD) | -111.6 M | -30.6 M | ||
| Diluted EPS (USD/shares) | -3.56 | -15.96 | -38.1 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-09-30 | 4 | FORM 4 | 2026-09-28 |
| 2026-09-29 | 4 | FORM 4 | 2026-09-25 |
| 2026-09-29 | 4 | FORM 4 | 2026-09-25 |
| 2026-08-24 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-08-24 | 8-K | 8-K items 7.01,8.01,9.01 | 2026-08-24 |
| 2026-08-07 | S-8 | S-8 | |
| 2026-08-06 | 10-Q | 10-Q | 2026-06-30 |
| 2026-08-06 | 8-K | 8-K items 2.02,9.01 | 2026-08-06 |
| 2026-08-03 | 3 | FORM 3 | 2026-08-01 |
| 2026-08-03 | 3 | FORM 3 | 2026-08-01 |
| 2026-08-03 | 3 | FORM 3 | 2026-08-01 |
| 2026-07-29 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-07-27 | 8-K | 8-K items 5.02,7.01,9.01 | 2026-07-23 |
| 2026-07-20 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-07-01 | 8-K | 8-K items 7.01,8.01,9.01 | 2026-07-01 |
| 2026-06-16 | 8-K | 8-K items 1.01,2.03,9.01 | 2026-06-10 |
| 2026-06-05 | 4 | FORM 4 | 2026-06-03 |
| 2026-06-05 | 4 | FORM 4 | 2026-06-03 |
| 2026-06-05 | 4 | FORM 4 | 2026-06-03 |
| 2026-06-05 | 4 | FORM 4 | 2026-06-03 |
| 2026-06-05 | 4 | FORM 4 | 2026-06-03 |
| 2026-06-03 | 4 | FORM 4 | 2026-06-01 |
| 2026-06-03 | 4 | FORM 4 | 2026-06-01 |
| 2026-06-03 | 4 | FORM 4 | 2026-06-01 |
| 2026-06-03 | 4 | FORM 4 | 2026-06-01 |
Forms on file (last 1,000): 4 238, 8-K 125, 144 38, 3 28, 10-Q 23, SC 13G/A 17, SC 13G 16, SCHEDULE 13G/A 15. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=DTIL (0.002 USD), /gw/filings/filings?ticker=DTIL&form=8-K, /gw/filings/facts?ticker=DTIL&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange